PT2268292T - Métodos e composições para o tratamento de cancro - Google Patents

Métodos e composições para o tratamento de cancro

Info

Publication number
PT2268292T
PT2268292T PT97237887T PT09723788T PT2268292T PT 2268292 T PT2268292 T PT 2268292T PT 97237887 T PT97237887 T PT 97237887T PT 09723788 T PT09723788 T PT 09723788T PT 2268292 T PT2268292 T PT 2268292T
Authority
PT
Portugal
Prior art keywords
cancer
compositions
treatment
Prior art date
Application number
PT97237887T
Other languages
English (en)
Portuguese (pt)
Inventor
Burger Angelika
Hendriks Hans
Rademaker Bernardus
Original Assignee
Kominox Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kominox Inc filed Critical Kominox Inc
Publication of PT2268292T publication Critical patent/PT2268292T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/36—Arsenic; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT97237887T 2008-03-27 2009-03-24 Métodos e composições para o tratamento de cancro PT2268292T (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3998708P 2008-03-27 2008-03-27
US12/408,864 US20090246291A1 (en) 2008-03-27 2009-03-23 Method and compositions for treatment of cancer

Publications (1)

Publication Number Publication Date
PT2268292T true PT2268292T (pt) 2018-02-19

Family

ID=41114644

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97237887T PT2268292T (pt) 2008-03-27 2009-03-24 Métodos e composições para o tratamento de cancro

Country Status (20)

Country Link
US (2) US20090246291A1 (OSRAM)
EP (1) EP2268292B1 (OSRAM)
JP (2) JP5543956B2 (OSRAM)
KR (1) KR101634138B1 (OSRAM)
CN (2) CN102046187A (OSRAM)
AU (1) AU2009228378B2 (OSRAM)
BR (1) BRPI0909164A2 (OSRAM)
CA (1) CA2719766C (OSRAM)
CY (1) CY1120536T1 (OSRAM)
DK (1) DK2268292T3 (OSRAM)
ES (1) ES2656762T3 (OSRAM)
HU (1) HUE036609T2 (OSRAM)
LT (1) LT2268292T (OSRAM)
MX (1) MX2010010621A (OSRAM)
PL (1) PL2268292T3 (OSRAM)
PT (1) PT2268292T (OSRAM)
RU (1) RU2508116C2 (OSRAM)
SI (1) SI2268292T1 (OSRAM)
WO (1) WO2009120697A2 (OSRAM)
ZA (1) ZA201006988B (OSRAM)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1721615A1 (en) 2005-05-09 2006-11-15 Komipharm International Co., Ltd. Pharmaceutical compositions comprising sodium or potassium arsenite for the treatment of urogenital cancer and its metastasis
US9447049B2 (en) 2010-03-01 2016-09-20 University Of Tennessee Research Foundation Compounds for treatment of cancer
PT2475362T (pt) * 2009-09-10 2019-05-27 Kominox Inc Terapia especifica para celulas estaminais cancerigenas e para 0 cancro resistente a medicamentos
US8795738B2 (en) * 2009-11-12 2014-08-05 Board Of Regents Of The University Of Texas System Use of arsenic for cancer therapy protection
US11084811B2 (en) 2010-03-01 2021-08-10 Oncternal Therapeutics, Inc. Compounds for treatment of cancer
EP2593101A4 (en) * 2010-07-18 2014-01-01 Niiki Pharma Inc POLYTHERAPY USING RUTHENIUM COMPLEX
WO2012027481A1 (en) * 2010-08-24 2012-03-01 Gtx, Inc. Compounds for treatment of cancer
US20120251628A1 (en) * 2011-03-30 2012-10-04 Young Joo Min Compositions and methods for treatment of cancer
JP2014513698A (ja) * 2011-05-12 2014-06-05 ボード・オヴ・リージェンツ，ユニヴァーシティ・オヴ・テキサス・システム がん治療保護のためのヒ素の使用
US8834938B2 (en) 2011-05-18 2014-09-16 Board Of Regents Of The University Of Texas System Use of arsenic for cancer therapy protection
US20160184356A1 (en) * 2013-03-15 2016-06-30 Ke Jian Jim Liu Arsenic-based treatment of cancers and inflammatory disorders
KR101309844B1 (ko) 2013-03-15 2013-09-23 박상채 항암 활성 증진용 한약재 및 이의 제조방법
JP6851826B2 (ja) * 2013-07-19 2021-03-31 オニキス セラピューティクス， インク．Ｏｎｙｘ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． がんの治療のためのｐｉｍキナーゼ阻害剤と組み合わせたペプチドエポキシケトンプロテアソーム阻害剤
PL3548044T3 (pl) 2016-12-01 2024-03-04 Eupharma Pty Ltd Kompozycje arsenu
MA52088A (fr) * 2018-03-22 2021-01-27 Komipharm Int Australia Pty Ltd Composition pharmaceutique comprenant du méta-arsénite et procédé de fabrication
CN116236505A (zh) * 2023-03-15 2023-06-09 上海市第四人民医院 三氧化二砷在制备肺神经内分泌癌治疗药物中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69840057D1 (de) * 1997-10-15 2008-11-06 Polarx Biopharmaceuticals Inc Pharmazeutische Zusammensetzungen enthaltend Arsentrioxid zur Behandlung von Krebs des zentralen Nervensystems
EP1964557B1 (en) * 1997-11-10 2013-01-02 Memorial Sloan-Kettering Cancer Center Process for producing arsenic trioxide formulations
KR20020083678A (ko) * 2001-04-28 2002-11-04 주식회사 한국미생물연구소 아르세닉산나트륨 염, 소디움 메타아르세나이트 또는 이의혼합물을 함유한 항암제 조성물
EP2042182B1 (en) * 2002-04-10 2013-05-22 Komipharm International Co., Ltd. Pharmaceutical composition comprising arsenite for the treatment of malignancy
EP1721615A1 (en) * 2005-05-09 2006-11-15 Komipharm International Co., Ltd. Pharmaceutical compositions comprising sodium or potassium arsenite for the treatment of urogenital cancer and its metastasis
US8097237B2 (en) * 2005-08-23 2012-01-17 Stc.Unm Non-invasive diagnostic agents of cancer and methods of diagnosing cancer, especially leukemia and lymphoma
US7867492B2 (en) * 2007-10-12 2011-01-11 The John Hopkins University Compounds for hedgehog pathway blockade in proliferative disorders, including hematopoietic malignancies

Also Published As

Publication number Publication date
ZA201006988B (en) 2012-05-30
SI2268292T1 (en) 2018-03-30
EP2268292A4 (en) 2011-05-11
CA2719766C (en) 2017-10-31
CA2719766A1 (en) 2009-10-01
WO2009120697A4 (en) 2010-04-15
CY1120536T1 (el) 2019-07-10
US20180055812A1 (en) 2018-03-01
JP2011515481A (ja) 2011-05-19
RU2010143893A (ru) 2012-05-10
WO2009120697A2 (en) 2009-10-01
PL2268292T3 (pl) 2018-06-29
MX2010010621A (es) 2011-04-05
WO2009120697A3 (en) 2010-02-18
DK2268292T3 (en) 2018-03-12
EP2268292B1 (en) 2017-12-27
AU2009228378B2 (en) 2014-07-17
KR101634138B1 (ko) 2016-06-28
US20090246291A1 (en) 2009-10-01
CN104997808A (zh) 2015-10-28
ES2656762T3 (es) 2018-02-28
JP5543956B2 (ja) 2014-07-09
LT2268292T (lt) 2018-03-26
HUE036609T2 (hu) 2018-07-30
JP2014101387A (ja) 2014-06-05
AU2009228378A1 (en) 2009-10-01
KR20110009664A (ko) 2011-01-28
EP2268292A2 (en) 2011-01-05
CN102046187A (zh) 2011-05-04
BRPI0909164A2 (pt) 2016-06-21
RU2508116C2 (ru) 2014-02-27

Similar Documents

Publication Publication Date Title
ZA201006988B (en) Method and compositions for treatment of cancer
IL267342A (en) Antibodies and preparations containing them for the treatment of cancer
IL218987A0 (en) Methods and compositions for treating cancer
PL2340042T3 (pl) Sposoby i kompozycje do leczenia raka
PT2200431T (pt) Novos métodos e composições para o tratamento do cancro
IL216926A0 (en) Diagnostic methods and compositions for treatment of cancer
ZA201105472B (en) Methods and compositions for diagnosis and treatment of cancer
SI3778885T1 (sl) Sestavki inženirskih humanih arginaz in metode za zdravljenje raka
EP2429584A4 (en) TREATMENT PROCEDURE AND COMPOSITIONS
IL214349A0 (en) Compositions and methods for the treatment of cancer
IL199689A0 (en) Compounds and method for treatment of cancer
EP2176406A4 (en) COMPOSITIONS AND METHOD FOR CANCER TREATMENT
EP2225226A4 (en) COMPOUNDS AND METHOD FOR THE TREATMENT OF CANCER
EP2515652A4 (en) COMPOSITIONS AND METHODS FOR TREATING VITILIGO
IL196727A0 (en) Composition and method for treatment of tumors
GB0808326D0 (en) Compositions and methods for the treatment of fybromyalgia
PT3067054T (pt) Novas composições e métodos para o tratamento de cancro